Lupin Upbeat On Biosimilar Etanercept After Q3 Profit Plunge

 
• By Penelope MacRae
  
Jigsaw
LUPIN REPORTED A WEAK QUARTER BUT IS UPBEAT ABOUT ITS BIOSIMILARS PORTFOLIO
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Earnings

More from Business